- Home
- NSPR vs PLRX Comparison
NSPR vs PLRX Comparison
Compare NSPR & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSPR
- PLRX
- Stock Information
- Founded
- NSPR 2005
- PLRX 2015
- Country
- NSPR United States
- PLRX United States
- Employees
- NSPR N/A
- PLRX N/A
- Industry
- NSPR Medical/Dental Instruments
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- NSPR Health Care
- PLRX Health Care
- Exchange
- NSPR Nasdaq
- PLRX Nasdaq
- Market Cap
- NSPR 75.1M
- PLRX 84.7M
- IPO Year
- NSPR N/A
- PLRX 2020
- Fundamental
- Price
- NSPR $2.44
- PLRX $1.28
- Analyst Decision
- NSPR Strong Buy
- PLRX Hold
- Analyst Count
- NSPR 2
- PLRX 10
- Target Price
- NSPR $4.50
- PLRX $9.79
- AVG Volume (30 Days)
- NSPR 44.5K
- PLRX 933.7K
- Earning Date
- NSPR 08-05-2025
- PLRX 08-06-2025
- Dividend Yield
- NSPR N/A
- PLRX N/A
- EPS Growth
- NSPR N/A
- PLRX N/A
- EPS
- NSPR N/A
- PLRX N/A
- Revenue
- NSPR $7,027,000.00
- PLRX N/A
- Revenue This Year
- NSPR $27.41
- PLRX N/A
- Revenue Next Year
- NSPR $127.08
- PLRX N/A
- P/E Ratio
- NSPR N/A
- PLRX N/A
- Revenue Growth
- NSPR 8.49
- PLRX N/A
- 52 Week Low
- NSPR $2.07
- PLRX $1.10
- 52 Week High
- NSPR $3.80
- PLRX $16.10
- Technical
- Relative Strength Index (RSI)
- NSPR 50.84
- PLRX 36.66
- Support Level
- NSPR $2.40
- PLRX $1.56
- Resistance Level
- NSPR $2.59
- PLRX $1.70
- Average True Range (ATR)
- NSPR 0.11
- PLRX 0.12
- MACD
- NSPR 0.00
- PLRX -0.02
- Stochastic Oscillator
- NSPR 57.50
- PLRX 5.68
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.